钙和维生素D补充与锯齿状息肉风险增加:一项随机临床试验结果
在基线有至少一个腺瘤的参与者中,随机接受每日1200 mg元素钙、1000 IU维生素D3、两者联合或均不补充,治疗3或5年后通过监测结肠镜评估息肉风险。治疗期未见钙或维生素D对无蒂锯齿状腺瘤/息肉(SSA/P)发生率的影响,但观察期钙单用和钙联合维生素D组SSA/P风险升高。
要点
- 治疗期钙或维生素D对SSA/P发生率无影响。
- 观察期钙单用和钙联合维生素D组SSA/P风险升高。
- 补钙和维生素D的潜在风险需与获益权衡。
核心结论
- 在这项大型多中心化学预防研究中,有证据表明补充钙和维生素D增加了SSA/P的风险,且似为补充开始后6-10年的迟发效应。
研究设计与样本
- 随机临床试验,基线有至少一个腺瘤的参与者随机接受每日1200 mg元素钙、1000 IU维生素D3、两者联合或均不补充,治疗持续3或5年。
主要发现
- 治疗期2058名参与者中565名(27.5%)诊断锯齿状息肉,观察期1108名中329名(29.7%)诊断锯齿状息肉,随访期间共识别211个SSA/P。
- 治疗期钙或维生素D对SSA/P发生率无影响。
- 观察期钙单用组SSA/P的aRR为2.65(95% CI 1.43至4.91),钙联合维生素D组aRR为3.81(95% CI 1.25至11.64)。
关键数值与推荐
- 钙单用组观察期SSA/P的aRR为2.65(95% CI 1.43至4.91)。
- 钙联合维生素D组观察期SSA/P的aRR为3.81(95% CI 1.25至11.64)。
临床怎么用
- 原文未据此给出推荐,作者指出这些可能的风险必须与补充钙和维生素D的获益相权衡。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Serrated lesions such as sessile serrated adenomas or polyps (SSA/Ps) are important colorectal cancer precursors, but aetiological factors for these lesions are largely unknown. We aimed to determine the effects of calcium and vitamin D supplementation on the incidence of serrated polyps (SPs) in general and hyperplastic polyps and SSA/Ps specifically. DESIGN: Participants with one or more adenoma at baseline were randomised to receive 1200 mg/day of elemental calcium, 1000 IU/day of vitamin D3, both or neither agent. Treatment continued for 3 or 5 years, when risk of polyps was determined from surveillance colonoscopy (treatment phase). Outcomes after treatment ceased were also assessed (observational phase). Adjusted risk ratios (aRRs) of SPs were determined via multivariable generalised linear models. RESULTS: SPs were diagnosed in 565 of 2058 (27.5%) participants during the treatment phase and 329/1108 (29.7%) during the observational phase. In total, 211 SSA/Ps were identified during follow-up. In the treatment phase, there was no effect of either calcium or vitamin D on incidence of SSA/Ps. However, during the later observational phase, we observed elevated risks of SSA/Ps associated with calcium alone and calcium+vitamin D treatment (aRR (95% CI): 2.65 (1.43 to 4.91) and 3.81 (1.25 to 11.64), respectively). CONCLUSION: In a large multicentre chemoprevention study, we found evidence that calcium and vitamin D supplementation increased the risk of SSA/Ps. This appeared to be a late effect: 6-10 years after supplementation began. These possible risks must be weighed against the benefits of calcium and vitamin D supplementation. : Trial registration NUMBER: NCT00153816; Results.
引用
- Crockett SD, Barry EL, Mott LA, et al. Calcium and vitamin D supplementation and increased risk of serrated polyps: results from a randomised clinical trial. Gut. 2018. PMID: 29496722. doi:10.1136/gutjnl-2017-315242
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。